DOCSLIB.ORG

Global Offering *

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Global Offering * LUZHOU XINGLU WATER XINGLU WATER LUZHOU 瀘 州 市 興 瀘 水 務 （ 集 團） 股 份有 限 公 司 ( GROUP (a joint stock company incorporated in the People’s Republic of China with limited liability) Stock Code: 2281 ) CO., LTD. GLOBAL OFFERING * Sole Sponsor and Sole Global Coordinator Joint Bookrunners and Joint Lead Managers * For identification purposes only IMPORTANT IMPORTANT: If you are in any doubt of the contents of this prospectus, you should obtain independent professional advice. Luzhou Xinglu Water (Group) Co., Ltd.* 瀘州市興瀘水務（集團）股份有限公司 (a joint stock company incorporated in the People’s Republic of China with limited liability) GLOBAL OFFERING Number of Offer Shares under the Global Offering : 214,940,000 H Shares (comprising 195,400,000 H Shares to be offered by the Company and 19,540,000 Sale Shares to be offered by the Selling Shareholders, subject to the Over-allotment Option) Number of Hong Kong Public Offer Shares : 21,494,000 H Shares (subject to adjustment) Number of International Offer Shares : 193,446,000 H Shares (comprising 173,906,000 H Shares to be offered by the Company and 19,540,000 Sale Shares to be offered by the Selling Shareholders, subject to adjustment and the Over-allotment Option) Maximum Offer Price : HK$2.53 per H Share, plus a brokerage of 1.0%, an SFC transaction levy of 0.0027% and a Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) Nominal Value : RMB1.00 per H Share Stock Code : 2281 Sole Sponsor and Sole Global Coordinator Joint Bookrunners and Joint Lead Managers Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus. A copy of this prospectus, having attached thereto the documents specified in the paragraph headed “Documents Delivered to the Registrar of CompaniesinHong Kong” in Appendix VII to this prospectus, has been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). The Securities and Futures Commission of Hong Kong and the Registrar of Companies in Hong Kong take no responsibility as to the contents of this prospectus or any other documents referred to above. Our Company is incorporated, and a substantial part of our businesses is located, in the PRC. Potential investors should be aware of the differences in legal, economic and financial systems between the PRC and Hong Kong and that there are different risk factors relating to the investments in our Company. Potential investors should also be aware that the regulatory frameworks in the PRC are different from the regulatory framework in Hong Kong and should take into consideration the different market nature of our H Shares. Such differences and risk factors are set out in the sections headed “Risk Factors” and “Regulatory Environment”, “Appendix IV — Summary of Principal Legal and Regulatory Provisions”, and “Appendix V — Summary of Articles of Association”. The Offer Price is expected to be fixed by agreement between the Sole Global Coordinator (for itself and on behalf of the Underwriters) and our Company (for ourselves and on behalf of the Selling Shareholders) on the Price Determination Date. The Price Determination Date is expected to be on or around Friday, 24 March 2017 and, in any event, not later than Wednesday, 29 March 2017. The Offer Price will not be more than HK$2.53 and is currently expected to be not less than HK$2.30 unless otherwise announced. Investors applying for Hong Kong Public Offer Shares must pay, on application, the maximum Offer Price of HK$2.53 for each H Share together with a brokerage of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005%. The Sole Global Coordinator (for itself and on behalf of the Underwriters), with the consent of our Company (for ourselves and on behalf of the Selling Shareholders), may reduce the number of Offer Shares being offered under the Global Offering and/or the indicative offer price range stated in this prospectus at any time prior to the morning of the last day for lodging applications under the Hong Kong Public Offering. In such a case, a notice of the reduction in the number of Offer Shares being offered under the Global Offering and/or of the indicative offer price range will be published on the website of the Stock Exchange at www.hkexnews.hk and our Company’s website at www.lzss.com not later than the morning of the last day for lodging applications under the Hong Kong Public Offering. Further details are set out in the sections headed “Structure of the Global Offering” and “How to Apply for Hong Kong Public Offer Shares” in this prospectus. If, for any reason, the Offer Price is not agreed between our Company (for ourselves and on behalf of the Selling Shareholders) and the Sole Global Coordinator (for itself and on behalf of the Underwriters) on or before Wednesday, 29 March 2017, the Global Offering will not proceed and will lapse. Prior to making an investment decision, prospective investors should consider carefully all of the information set out in this prospectus and the related Application Forms, including the risk factors set out in the section headed “Risk Factors” in this prospectus. Pursuant to the termination provisions contained in the Underwriting Agreements in respect of the Offer Shares, the Sole Global Coordinator, for itself and on behalf of the Underwriters, has the right in certain circumstances, in the sole discretion of the Sole Global Coordinator, to terminate the obligations of the Underwriters pursuant to the Underwriting Agreements at any time prior to 8:00 a.m. (Hong Kong time) on the date when dealings in our H Shares first commence on The Stock Exchange of Hong Kong Limited (such first dealing date is currently expected to be on Friday, 31 March 2017). Further details of the terms of the termination provisions are set out in the paragraph headed “Underwriting Arrangements and Expenses — Hong Kong Public Offering — Grounds from termination” under the section headed “Underwriting” in this prospectus. It is important that you refer to that section for further details. The Offer Shares have not been, and will not be, registered under the U.S. Securities Act or any state securities laws of the United States and may not be offered, sold, pledged or transferred within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. The Offer Shares may only be offered, sold or delivered outside the United States in offshore transactions in reliance on Regulation S under U.S. Securities Act. * For identification purposes only 21 March 2017 EXPECTED TIMETABLE(1) Our Company will issue an announcement in Hong Kong to be published on the website of the Stock Exchange at www.hkexnews.hk and our Company’s website at www.lzss.com if there is any change in the following expected timetable of the Hong Kong Public Offering. Latest time to complete electronic applications under the White Form eIPO service through the designated website www.eipo.com.hk(2) .............................11:30 a.m. on Friday, 24 March 2017 Application lists open(3) .............................................11:45 a.m. on Friday, 24 March 2017 Latest time for lodging WHITE and YELLOW Application Forms ...............................................12:00 noon on Friday, 24 March 2017 Latest time for giving electronic application instructions to HKSCC(4) ...................................................12:00 noon on Friday, 24 March 2017 Latest time to complete payment of White Form eIPO applications by effecting internet banking transfer(s) or PPS payment transfer(s) ........................................12:00 noon on Friday, 24 March 2017 Application lists close(3) ............................................12:00 noon on Friday, 24 March 2017 Expected Price Determination Date(5)...........................Friday, 24 March 2017 Announcement of: (i) the Offer Price; (ii) the level of indication of interest in the International Offering; (iii) the level of application in respect of the Hong Kong Public Offering; and (iv) the basis of allotment of the Hong Kong Public Offering (with successful applicants’ identification document numbers, where applicable) to be published on our Company’s website at www.lzss.com and the Stock Exchange’s website at www.hkexnews.hk onorbefore.........................................Thursday, 30 March 2017 –i– EXPECTED TIMETABLE(1) Results of allocations in the Hong Kong Public Offering (with successful applicants’ identification document numbers, where appropriate) to be available through a variety of channels as described in the subsection entitled “How to Apply for Hong Kong Public Offer Shares — Publication of Results” in this prospectus from ...............Thursday, 30 March 2017 Results of allocations in the Hong Kong Public Offering will be available at www.iporesults.com.hk with a “search by ID” function from........................Thursday, 30 March 2017 Despatch of H Share certificates in respect of wholly or partially successful applications on or before(6) ...............Thursday, 30 March 2017 Despatch of refund cheques or White Form e-Refund payment instructions in respect of wholly or partially unsuccessful applications on or before(7) (8) ...........Thursday, 30 March 2017 Dealings in the H Shares on the Stock Exchange to commence on ..........................................Friday, 31 March 2017 Notes: (1) All dates and times refer to Hong Kong local dates and times, except as otherwise stated.
Load more

Recommended publications
  • US EPA, Pesticide Product Label, MAXUNITECH SULFENTRAZONE TC,10/02/2020
    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, DC 20460 OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION October 2, 2020 Katy DeGroot Regulatory Consultant for Oriental (Luzhou) Agrochemicals Co., LTD c/o Pyxis Regulatory Consulting, Inc. 4110 136TH Street CT NW Gig Harbor, WA 98332 Subject: Notification per PRN 98-10 – Minor label revision; adding internal label code Product Name: Maxunitech Sulfentrazone TC EPA Registration Number: 89858-1 Application Date: August 18, 2020 Decision Number: 566406 Dear Ms. DeGroot: The Agency is in receipt of your Application for Pesticide Notification under Pesticide Registration Notice (PRN) 98-10 for the above referenced product. The Registration Division (RD) has conducted a review of this request for its applicability under PRN 98-10 and finds that the action requested falls within the scope of PRN 98-10. The label submitted with the application has been stamped “Notification” and will be placed in our records. Should you wish to add/retain a reference to the company’s website on your label, then please be aware that the website becomes labeling under the Federal Insecticide Fungicide and Rodenticide Act and is subject to review by the Agency. If the website is false or misleading, the product would be misbranded and unlawful to sell or distribute under FIFRA section 12(a)(1)(E). 40 CFR 156.10(a)(5) list examples of statements EPA may consider false or misleading. In addition, regardless of whether a website is referenced on your product’s label, claims made on the website may not substantially differ from those claims approved through the registration process.
    [Show full text]
  • Table of Codes for Each Court of Each Level
    Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115
    [Show full text]
  • Lung-Targeting Drug Delivery System of Baicalin- Loaded
    Journal name: International Journal of Nanomedicine Article Designation: Original Research Year: 2017 Volume: 12 International Journal of Nanomedicine Dovepress Running head verso: Wei et al Running head recto: Lung-targeting drug delivery system of baicalin-loaded nanoliposomes open access to scientific and medical research DOI: http://dx.doi.org/10.2147/IJN.S119895 Open Access Full Text Article ORIGINAL RESEARCH Lung-targeting drug delivery system of baicalin- loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer Yumeng Wei1 Abstract: The present study aims to develop a kind of novel nanoliposomes for the lung-targeting Jing Liang1 delivery system of baicalin as a Chinese medicine monomer. Baicalin-loaded nanoliposomes Xiaoli Zheng2 were prepared by the effervescent dispersion and lyophilized techniques. Baicalin-loaded Chao Pi1 nanoliposomes had an average particle size of 131.7±11.7 nm with 0.19±0.02 polydispersity Hao Liu1 index, 82.8%±1.24% entrapment efficiency and 90.47%±0.93% of yield and sustaining drug Hongru Yang3 release effect over 24 h and were stable for 12 months at least. In vitro no hemolytic activity was observed for the experimental drug concentration. After intravenous administration of Yonggen Zou4 baicalin-loaded nanoliposomes to rabbits, drug concentration in the lungs was the highest among Yun Ye1,5 the tested organs at all time points and was significantly higher than that of its solution. For the 1 Ling Zhao targeting parameters, the relative intake rate and the ratio of peak concentration of lung were 1Department of Pharmaceutics, 4.837 and 2.789, respectively.
    [Show full text]
  • Yunnan Provincial Highway Bureau
    IPP740 REV World Bank-financed Yunnan Highway Assets management Project Public Disclosure Authorized Ethnic Minority Development Plan of the Yunnan Highway Assets Management Project Public Disclosure Authorized Public Disclosure Authorized Yunnan Provincial Highway Bureau July 2014 Public Disclosure Authorized EMDP of the Yunnan Highway Assets management Project Summary of the EMDP A. Introduction 1. According to the Feasibility Study Report and RF, the Project involves neither land acquisition nor house demolition, and involves temporary land occupation only. This report aims to strengthen the development of ethnic minorities in the project area, and includes mitigation and benefit enhancing measures, and funding sources. The project area involves a number of ethnic minorities, including Yi, Hani and Lisu. B. Socioeconomic profile of ethnic minorities 2. Poverty and income: The Project involves 16 cities/prefectures in Yunnan Province. In 2013, there were 6.61 million poor population in Yunnan Province, which accounting for 17.54% of total population. In 2013, the per capita net income of rural residents in Yunnan Province was 6,141 yuan. 3. Gender Heads of households are usually men, reflecting the superior status of men. Both men and women do farm work, where men usually do more physically demanding farm work, such as fertilization, cultivation, pesticide application, watering, harvesting and transport, while women usually do housework or less physically demanding farm work, such as washing clothes, cooking, taking care of old people and children, feeding livestock, and field management. In Lijiang and Dali, Bai and Naxi women also do physically demanding labor, which is related to ethnic customs. Means of production are usually purchased by men, while daily necessities usually by women.
    [Show full text]
  • Download Article
    Advances in Social Science, Education and Humanities Research, volume 357 2nd International Conference on Education, Economics and Social Science (ICEESS 2019) Study on Modern Agricultural Development in Mountainous Areas of Xingwen County Ge He Management school of Sichuan agricultural university Chengdu, China Abstract—This paper aims at analyzing favorite conditions of and the tertiary industry were respectively 2.02 billion Yuan, modern agricultural development in mountainous areas of 3.38 billion Yuan and 4.42 billion Yuan. Although Xingwen Xingwen county and introducing the existing issues used field County has made remarkable achievements in the development survey method. The results find Xingwen has the favorite of modern agriculture in the past few decades, on one hand, it conditions of modern agriculture development:(1)rich in natural is far away from the central city because of its geographical and human resources;(2)convenient transportation; (3) good location and relatively backward social and economic agricultural development trend;(4) significant performance of development; on the other hand, because it is located in the tourism development ;(5)government’s importance. To improve Women Mountains, the use of agricultural machinery is it, the government should :(1)promote the organic integration of restricted by geographical conditions, and the means of agriculture and rural tourism;(2)develop appreciate scale production are relatively primitive; on the other hand, Xingwen management ; (3) develop brand agriculture based on market County is located in the Wumeng Mountains. Additionally, demand. Because of the small scale of agricultural production and Keywords—modern agriculture; agricultural development; operation, there is still a lack of channels for traditional Xingwen County agriculture to enter the modern market.
    [Show full text]
  • Efficacy of Additional Corticosteroids to Multimodal Cocktail Periarticular
    Li et al. Journal of Orthopaedic Surgery and Research (2021) 16:200 https://doi.org/10.1186/s13018-021-02317-5 CORRECTION Open Access Correction to: Efficacy of additional corticosteroids to multimodal cocktail periarticular injection in total knee arthroplasty: a meta-analysis of randomized controlled trials Qi Li1, Guo Mu2, Xiangbo Liu3 and Milian Chen1* Correction to: J Orthop Surg Res 16, 77 (2021) https://doi.org/10.1186/s13018-020-02144-0 Following the publication of the original article [1], the authors found out mistake on the affiliation section. Reference They did not find this error during proofreading. The 1. Li Q, Mu G, Liu X, et al. Efficacy of additional corticosteroids to multimodal authors would like to apologize for this mistake. cocktail periarticular injection in total knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2021;16:77 https://doi.org/1 The order of all authors remains the same, but the 0.1186/s13018-020-02144-0. error lies on affiliations 2 and 3. The correct affiliations are shown below. These have also been updated in this article. 2 Department of Anesthesiology, Zigong Fourth People’s Hospital, NO.19 Tanmulin Street, Ziliujin, Zigong 643000, Sichuan Province, People’s Republic of China. 3 Southwest Medical University, NO.319, Section 3, Zhongshan road, Jiangyang District, Luzhou 643000, Sichuan Province, People’s Republic of China. Author details 1Department of Anesthesiology, Shehong People’s Hospital, NO.19, Guanghan road, Shehong 629200, Sichuan Province, People’s Republic of China. 2Department of Anesthesiology, Zigong Fourth People’s Hospital, NO.19 Tanmulin Street, Ziliujin, Zigong 643000, Sichuan Province, People’s Republic of China.
    [Show full text]
  • 2021033003506.Pdf
    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 6806) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020 The board of directors (the “Board”) of Shenwan Hongyuan Group Co., Ltd. (the “Company”) hereby announces the audited results of the Company and its subsidiaries for the year ended December 31, 2020. This results announcement, containing the full text of the 2020 annual report of the Company, complies with the relevant requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited in relation to the information to accompany preliminary announcement of annual results. The Company’s annual results for the year ended December 31, 2020 have been reviewed by the audit committee of the Board. This results announcement will be published on the HKEXnews website of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk) and the website of the Company (www.swhygh.com) respectively. The 2020 annual report will be dispatched to the H shareholders of the Company and published on the HKEXnews website of Hong Kong Exchanges and Clearing Limited and the website of the Company in due course. By Order of the Board Shenwan Hongyuan Group Co., Ltd.
    [Show full text]
  • Luzhou Bank Co., Ltd.* 瀘州銀行股份有限公司 *
    THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to any aspect of this Circular or as to the action to be taken, you should consult your stockbroker or other registered dealer in securities, a bank manager, solicitor, professional accountant or other professional adviser. If you have sold or transferred all your shares in Luzhou Bank Co., Ltd.*, you should at once pass this Circular and the enclosed form of proxy and reply slip to the purchaser or the transferee, the bank, the stockbroker or other agent through whom the sale or transfer was affected for transmission to the purchaser or the transferee. Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited take no responsibility for the contents of this Circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Circular. This Circular is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities or an invitation to enter into an agreement to do so, nor is it calculated to invite any offer to acquire, purchase or subscribe for any securities. Luzhou Bank Co., Ltd.* 瀘州銀行股份有限公司* (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 1983) (1) PROPOSED WRITE-OFF OF CERTAIN NON-PERFORMING LOANS; AND (2) NOTICE OF 2019 SECOND EXTRAORDINARY GENERAL MEETING A notice convening the Extraordinary General Meeting of the Bank to be held at 9:00 a.m.
    [Show full text]
  • 航协号 公司英文名称 到帐日期 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
    航协号 公司英文名称 到帐日期 1 8010026 SHISHI QIAOLIAN TRAVEL & 16.12.2014 2 8010030 BEIJING XUEYUANLU AIR PASSENGE 18.12.2014 3 8010262 BEIJING XINGZHONGBIN AIR 08.12.2014 4 8010424 SHANGHAI INTERNATIONAL 04.12.2014 5 8010483 BEIJING GONGZHUFEN AIR TICKET 22.12.2014 6 8010494 SHANGHAI XIN GUO AIR 04.12.2014 7 8010564 GUILIN GUIKANG TICKETS CO LTD 10.12.2014 8 8010704 CIXI XUNDA AIR TICKETS 03.12.2014 9 8010774 BEIJING ZHENG XIANG AIR 17.12.2014 10 8010811 FUJIAN KANGTAI INTERNATIONAL 08.12.2014 11 8010822 ZHEJIANG FOREIGN AFFAIRS 10.12.2014 12 8010833 LIAN JIANG AIRLINE 19.12.2014 13 8010881 SHENZHEN WANGYUN KUNMING 26.12.2014 14 8011006 FUJIAN RAILWAYS INT'L 08.12.2014 15 8011290 FUZHOU JINYUN HANGKONG HANGYUN 04.12.2014 16 8011441 LIAONING JIANTONG AIR SERVICE 12.12.2014 17 8011474 BEIJING ZI LANG AIR 11.12.2014 18 8011544 BEIJING LANYUXING AIR 12.12.2014 19 8011570 THE QIAOLIAN TRAVEL 08.12.2014 20 8011581 SHENZHEN YOUSHI AIR 18.12.2014 21 8011802 SHENZHEN ZHONGHAOHUI AIR PAX 08.12.2014 22 8011824 BEIJING ZHAORI AVIATION 05.12.2014 23 8011850 SUCCESSFUL AIR AGENCY 05.12.2014 24 8011872 BEIJING TIAHONG YUANDU 04.12.2014 25 8012045 BEIJING HANGTIAN MIANYUAN AIR 23.12.2014 26 8012104 BEIJING TONGSHANGYUNDA 12.12.2014 27 8012115 BEIJING QING YE AIR 17.12.2014 28 8012325 QINHUANGDAO HONGYUAN KONGYUN 09.12.2014 29 8012336 HANDAN NEW CENTURY 11.12.2014 30 8012384 BEIJINGRUIFENG XINCHENG 11.12.2014 31 8012443 BEIJING GENERALWAY AIR SERVICE 17.12.2014 32 8012546 DONGGUAN GUOTAI TRANSPORT CO.L 23.12.2014 33 8012572 GUANGZHOU JIAOYIHUI INTL 09.12.2014 34
    [Show full text]
  • Global Offering
    瀘州市商業銀行股份有限公司 Luzhou City Commercial Bank Co., Ltd. (A joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 1983 Global offerinG Sole Sponsor Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers Joint Lead Managers IMPORTANT IMPORTANT: If you are in doubt about any information contained in this prospectus you should obtain independent professional advice. Luzhou City Commercial Bank Co., Ltd.* 瀘州市商業銀行股份有限公司* (A joint stock company incorporated in the People’s Republic of China with limited liability) GLOBAL OFFERING Number of Offer Shares in the : 545,740,000 H Shares (subject to the Global Offering Over-allotment Option) Number of International Offer Shares : 491,166,000 H Shares (subject to adjustment and the Over-allotment Option) Number of Hong Kong Offer Shares : 54,574,000 H Shares (subject to adjustment) Maximum Offer Price : HK$3.40 per H Share, plus brokerage of 1%, SFC transaction levy of 0.0027% and Hong Kong Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars, subject to refund) Nominal value : RMB1.00 per H Share Stock code : 1983 Sole Sponsor Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers Joint Lead Managers Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus.
    [Show full text]
  • Luzhou Xinglu Water
    Luzhou Xinglu Water (Group) Co., Ltd.* 瀘州市興瀘水務（集 團）股份有限公司 (a joint stock company incorporated in the People’s Republic of China with limited liability) (Stock code: 2281) REPLY SLIP 2020 ANNUAL GENERAL MEETING To: Luzhou Xinglu Water (Group) Co., Ltd. (the “Company”) Name(s) and registered address(es) of shareholder(s) (Note 1) Number of shares held (Note 2): domestic shares/ H shares I/We intend to attend (in person or by proxy(ies)) the 2020 annual general meeting of the Company to be held at the meeting room of 6th Floor, 16 Baizi Road, Jiangyang District, Luzhou, Sichuan Province, the People’s Republic of China (the “PRC”) at 9:30 a.m. on Friday, 11 June 2021. Date: 2021 Signature of shareholder(s): Name of shareholder(s): Notes: 1. Please insert full name(s) (in Chinese or English) and registered address(es) as shown on the register of members in BLOCK letters. 2. Please insert the number of shares registered in your name(s) and delete as inappropriate. If no number is inserted, this reply slip will be deemed to relate to all shares in the capital of the Company registered in your name(s). 3. Reference is made to the notice of the 2020 annual general meeting of the Company dated 7 May 2021. 4. This completed and signed reply slip should be returned to the Company on or before Saturday, 22 May 2021. For holders of domestic shares of the Company, the reply slip should be lodged with the Company’s board office located at the registered office of the Company in the PRC at 16 Baizi Road, Jiangyang District, Luzhou, Sichuan Province, the PRC, by hand or by post.
    [Show full text]
  • US EPA, Pesticide Product Label, MAXUNITECH SULFENTRAZONE TC,10/17/2018
    U.S. ENVIRONMENTAL PROTECTION AGENCY EPA Reg. Number: Date of Issuance: Office of Pesticide Programs Registration Division (7505P) 89858-1 10/17/18 1200 Pennsylvania Ave., N.W. Washington, D.C. 20460 NOTICE OF PESTICIDE: Term of Issuance: X Registration Reregistration Unconditional (under FIFRA, as amended) Name of Pesticide Product: Maxunitech Sulfentrazone TC Name and Address of Registrant (include ZIP Code): Oriental(Luzhou) Agrochemical Co., Ltd c/o Pyxis Regulatory Consulting Inc. 4110 136th St. Ct. NW Gig Harbor, WA 98332 Note: Changes in labeling differing in substance from that accepted in connection with this registration must be submitted to and accepted by the Registration Division prior to use of the label in commerce. In any correspondence on this product always refer to the above EPA registration number. On the basis of information furnished by the registrant, the above named pesticide is hereby registered under the Federal Insecticide, Fungicide and Rodenticide Act. Registration is in no way to be construed as an endorsement or recommendation of this product by the Agency. In order to protect health and the environment, the Administrator, on his motion, may at any time suspend or cancel the registration of a pesticide in accordance with the Act. The acceptance of any name in connection with the registration of a product under this Act is not to be construed as giving the registrant a right to exclusive use of the name or to its use if it has been covered by others. This product is unconditionally registered in accordance with FIFRA section 3(c)(5) provided that you: 1.
    [Show full text]